• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 207/22 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Patent holdings for IPC class C07D 207/22

Total number of patents in this class: 126

10-year publication summary

12
7
9
7
10
6
11
10
6
0
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
ObsEva S.A.
62
12
FMC Corporation
850
8
Allergan, Inc.
2431
6
Bayer Cropscience AG
2136
6
KYORIN Pharmaceutical Co., Ltd.
173
6
Abbvie Inc.
1785
4
Glaxo Group Limited
4250
3
Novartis AG
11254
3
Bristol-myers Squibb Company
4861
3
Takeda Pharmaceutical Company Limited
2945
3
Merck Patent GmbH
5856
2
Centre National de La Recherche Scientifique
10140
2
Aix-Marseille Universite'
37
2
Cancer Research Technology Limited
524
2
Galderma Research & Development
416
2
Inserm (institut National de La Sante et de La Recherche Medicale)
3359
2
Institut Jean Paoli & Irene Calmettes
127
2
Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
67
2
Calico Life Sciences LLC
85
2
Canwell Biotech Limited
17
2
Other owners 52